Recent Quarter Total Invested
$24.83 M
Recent Quarter Institutional Ownership Percentage
60.31%
Total Invested of Last Quarter
$18.08 M
Ownership Percentage of Last Quarter
55.08%
Achilles Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 4.10 M | $4.18 M | 555.82% | 10.16% |
| FCPM III SERVICES B.V. | 11/14/2024 | 2.39 M | $2.44 M | 0.00% | 5.92% |
| REDMILE GROUP, LLC | 11/14/2024 | 1.61 M | $1.64 M | 0.00% | 3.98% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.50 M | $1.53 M | 0.00% | 3.72% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 1.44 M | $1.47 M | 0.00% | 3.58% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 638,133 | $650,896 | -6.53% | 1.58% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 420,481 | $428,891 | 0.00% | 1.04% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 250,825 | $255,000 | 0.00% | 0.62% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 22,400 | $22,848 | -4.68% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 21,590 | $22,021 | 0.00% | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 21,249 | $21,674 | -1.07% | 0.05% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/13/2024 | 20,000 | $20,400 | 100.00% | 0.05% |
| MORGAN STANLEY | 11/14/2024 | 16,431 | $16,760 | 83.98% | 0.04% |
| BAADER BANK AKTIENGESELLSCHAFT | 10/29/2024 | 14,184 | $10,365 | 14.67% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 12,434 | $12,683 | 100.00% | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 10/10/2024 | 10,000 | $10,200 | 0.00% | 0.02% |
| RHUMBLINE ADVISERS | 11/12/2024 | 4,480 | $4,569 | 0.00% | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 10/29/2024 | 3,000 | $3,060 | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 11/08/2024 | 137 | $140 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 15 | $15,000 | 100.00% | 0.00% |
| ARTAL GROUP S.A. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/16/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Achilles Therapeutics plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ACHL shares?
During the previous two years, 30 institutional investors and hedge funds held shares of Achilles Therapeutics plc. The most heavily invested institutionals were:
BML Capital Management, LLC: 4.1 M
FCPM III SERVICES B.V.: 2.39 M
Redmile Group, LLC: 1.61 M
Vestal Point Capital, LP: 1.5 M
Ikarian Capital, LLC: 1.44 M
RENAISSANCE TECHNOLOGIES LLC: 638,133
-
What percentage of Achilles Therapeutics plc stock is owned by institutional investors?
60.31% of Achilles Therapeutics plc stock is owned by institutional investors.
-
How much institutional buying is happening at ACHL ?
Institutional investors have bought a total of 12.50 M shares in the last 24 months. This purchase volume represents approximately $13.12 M in transactions.